TQB2210
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 22, 2025
Clinical Trial to Evaluate the Tolerance of TQB2210 Injection
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
April 16, 2025
Clinical Trial to Evaluate the Tolerance of TQB2210 Injection
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
New P1 trial • Solid Tumor
1 to 2
Of
2
Go to page
1